Bullous pemphigoid in young patients: A retrospective study of 74 cases;Pemphigoïde du sujet jeune: Étude rétrospective de 74 cas

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 2, 2005, Pages 115-122

  Bourdon Lanoy, E ^a   Roujeau, J C ^a   Joly, P ^b   Guillaume, J C ^c   Bernard, P ^d   Prost, C ^e   Tancrede Bohin E ^e   Delaporte, E ^f   Picard Dahan, C ^g   Albes, B ^h   Bedane, C ⁱ   Doutre, M S ^j   Chosidow, O ^k   Lok, C ^l   Pauwels, C ^m   Chevrand Breton, J ⁿ   Sassolas, B ^o   Richard, M A ^p  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c Pasteur Hospital   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g BICHAT HOSPITAL   (France)

^h CHU PURPAN   (France)

ⁱ DUPUYTREN UNIVERSITY HOSPITAL   (France)

^j HAUT LÉVÊQUE HOSPITAL   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l AMIENS UNIVERSITY HOSPITAL   (France)

^m CENTRE HOSPITALIER INTERCOMMUNAL   (France)

ⁿ PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^o CHU MORVAN   (France)

^p HÔPITAL SAINTE MARGUERITE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BULLOUS PEMPHIGOID ANTIBODY 180; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNITY; BASEMENT MEMBRANE; FEMALE; HEMIDESMOSOME; HUMAN; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; LICHEN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PEMPHIGOID; PSORIASIS; PUVA; QUESTIONNAIRE; RETROSPECTIVE STUDY;

EID: 20144374922     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(05)79220-6     Document Type: Article

References (37)

1. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 1995;131:48-52.
2. Bernard P, Bedane C, Bonnetblanc JM. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Br J Dermatol 1997;136:694-8.
3. Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002;346:321-7.
4. Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol 1996;132:272-6.
5. Vaillant L, Bernard P, Joly P, Prost C, Labeille B, Bedane C et al. Evaluation of clinical criteria for diagnosis of bullous pemphigoid. Arch Dermatol 1998;134:1075-80.
6. Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 1998;134:465-9.
7. Korman N. Bullous pemphigoid. J Am Acad Dermatol 1987;16:907-24.
8. Lazarova Z, Yancey KB. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations. J Am Acad Dermatol 1996;35:398-403.
9. Stanley JR, Woodley DT, Katz SI. Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol 1984;82:108-11.
10. Mueller S, Klaus-Kovtun V, Stanley JR. A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 1989;92:33-8.
11. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986;136:1231-5.
12. Joly P, Gilbert D, Thomine E, Delpech A, Courville P et al. Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid. Arch Dermatol 1997;133:719-24.
13. Prost C, Dubertret L, Fosse M, Wechsler J, Touraine R. A routine immuno-electron microscopic technique for localizing an auto-antibody on epidermal basement membrane. Br J Dermatol 1984;110:1-7
14. Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 1999;41:266-8.
15. Schmidt E, Obe K, Brocker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000;136:174-8.
16. Brown MD, Dubin HV. Penicillamine-induced bullous pemphigoid-like eruption. Arch Dermatol 1987;12:1119-20.
17. Fellner MJ, Katz JM. Occurrence of bullous pemphigoid after furosemide therapy. Arch Dermatol 1976;112:75-7.
18. Grange F, Scrivener Y, Koessler A, Straub P, Guillaume JC. Pemphigoïde induite par la spironolactone. Ann Dermatol Venereol 1997;124: 700-2.
19. Modeste AB, Cordel N, Courville P, Gilbert D, Lauret P, Joly P. Pemphigoïde régressive après arrêt d'un diurétique contenant de l'aldactone. Ann Dermatol Venereol 2002;129:56-8.
20. Leconte-Boulard C, Dompmartin A, Verneuil L, Thomine E, Joly P, Rogerie MJ, Leroy D. Pemphigoïde localisée après radiothé rapie. Ann Dermatol Venereol 2000;127:70-2.
21. Brun P, Baran R. Pemphigoíde bulleuse induite par la photochimiothérapie du psoriasis. A propos de 2 cas, avec revue de la littérature. Ann Dermatol Venereol 1982;109:461-8.
22. Bastian P, Drobacheff C, Laurent R. Pemphigoïdes bulleuses déclenchées par la PUVAthérapie. Ann Dermatol Venereol 1990;117:734.
23. Cram DL, Fukuyama K. Immunohistochemistry of ultraviolet-induced pemphigus and pemphigoid lesions. Arch Dermatol 1972;106:819-24.
24. Koerber WA, Price NM, Watson W. Coexistent psoriasis and bullous pemphigoid. Arch Dermatol 1978;114:1643-6.
25. Weber PJ, Salazar JE. Bullous eruption in a psoriatic patient. Arch Dermatol 1989;125:693-4.
26. Joshi RK, Atukorala DN, Abanmi A, Al Awadi T. Lichen planus pemphigoides. Is it a separate entity. Br J Dermatol 1994;130:537-46.
27. Masouyé I, Schmied E, Didierjean L, Abba Z, Saurat JH. Bullous pemphigoid and multiple sclerosis: more than a coincidence? J Am Acad Dermatol 1989;21:63-8.
28. Chosidow O, Doppler V, Bensimon G, Joly P, Salachas F, Lacomblez L et al. Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease. Arch Dermatol 2000;136:521-4.
29. Foureur N, Descamps V, Lebrun-Vignes B, Picard-Dahan C, Grossin M, Belaich S, Crickx B. Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? Eur J Dermatol 2001;11:230-3.
30. Cordel N, Chosidow O, Hautemaniere A, Roujeau JC, Vaillant L, Delaporte E et al. Evaluation de l'atteinte neurologique au cours de la pemphigoide bulleuse. Ann Dermatol Venereol 2000;127 Suppl (S4):3.
31. Lindelöf B, Islam N, Eklund G, Arfors L. Pemphigoid and cancer. Arch Dermatol 1990;126:66-8.
32. Stone SP, Schroeter AL. Bullous pemphigoid and associated malignant neoplasms. Arch Dermatol 1975;11:991-4.
33. Venning VA, Wojnarowska F. The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol 1990;123:439-45.
34. Millard TP, Smith HR, Black MM, Barker JN. Bullous pemphigoid developing during systemic therapy with chloroquine. Clin Exp Dermatol 1999;24:263-5.
35. Barth JH, Kelly SE, Wojnarowska F, Savin JA, Whittaker S, Cream JJ, White JE. Pemphigoid and ulcerative colitis. J Am Acad Dermatol 1988;19:303-8.
36. Harrison PV, Blewitt RW, Allen J, Wojnarowska F, Adamson AR, Jones CJP, Aplin JD, Church HJ. Bullous pemphigoid and ulcerative colitis: a report of two cases and description of immunoblot findings. Br J Dermatol 1996;134:599-600.
37. Kaplan RP. Bullous pemphigoid and ulcerative colitis. Arch Dermatol 1991;127:1728-9.